Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Other

Gastroesophageal reflux disease

Tracked across 1 events · 32 articles · First seen Aug 20, 2026 · Last active Sep 08, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Regulatory
Implantica AG, a Liechtenstein-based medtech company, received Premarket Approval (PMA) from the U.S. United States — Food and Drug Administration (FDA) for its RefluxStop device, an implantable treatment for gastroesophageal reflux disease (GERD). The approval,…
Impact: GERD is the medical condition treated by RefluxStop, with a large global patient population, underpinning the market opportunity.
Aug 20, 2026 · 32 articles
ERGEN INTELLIGENCE
Track Gastroesophageal reflux disease live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.